Next-generation antibody discovery platforms

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 45, 2012, Pages 18245-18246

  Hardiman, Gary ^a,b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; ANTIGEN; BINDING PROTEIN; IMMUNOGLOBULIN; POLYPEPTIDE; REAGENT;

ANTIBODY LIBRARY; ANTIBODY PRODUCTION; ANTIBODY STRUCTURE; ANTIGEN BINDING; BACTERIUM TRANSFORMATION; CODON; DNA SEQUENCE; GENE; HIGH THROUGHPUT SEQUENCING; IMMUNE SYSTEM; NOTE; PHENOTYPE; PRIORITY JOURNAL; RIBOSOME;

ANTIBODIES; HUMANS; PEPTIDE LIBRARY; SEQUENCE ANALYSIS, DNA;

EID: 84868563293     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1216406109     Document Type: Note

References (11)

1. Larman HB, Xu GJ, Pavlova NN, Elledge SJ (2012) Construction of a rationally designed antibody platform for sequencing-assisted selection. Proc Natl Acad Sci USA 109:18523-18528.
2. Fischer N (2011) Sequencing antibody repertoires: the next generation. MAbs 3(1):17-20.
3. Wu TT, Kabat EA (1970) An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med 132(2):211-250.
4. Hardiman G (2012) Application of ultra-high throughput sequencing and microarray technologies in pharmacogenomics testing. Therapeutic Drug Monitoring, ed Dasgupta A (Elsevier, London), pp 144-159.
5. Ravn U, et al. (2010) By-passing in vitro screening - next generation sequencing technologies applied to antibody display and in silico candidate selection. Nucleic Acids Res 38(21):e193.
6. Beck A, Wurch T, Bailly C, Corvaia N (2010) Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 10(5):345-352.
7. Talapatra A, Rouse R, Hardiman G (2002) Protein microarrays: challenges and promises. Pharmacogenomics 3(4):527-536. (Pubitemid 34814680)
8. Hoogenboom HR (2005) Selecting and screening recombinant antibody libraries. Nat Biotechnol 23(9):1105-1116.
9. Lloyd C, et al. (2009) Modelling the human immune response: Performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng Des Sel 22(3):159-168.
10. Rothe C, et al. (2008) The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. J Mol Biol 376(4):1182-1200.
11. Hanes J, Schaffitzel C, Knappik A, Plückthun A (2000) Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat Biotechnol 18(12):1287-1292.